Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $188.03 | 3 | 82.2% |
| Education | $40.69 | 3 | 17.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tactile Systems Technology Inc | $112.34 | 2 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $75.69 | 1 | $0 (2023) |
| CSL Behring | $16.48 | 1 | $0 (2021) |
| Seattle Genetics, Inc. | $12.29 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $75.69 | 1 | Karyopharm Therapeutics Inc. ($75.69) |
| 2022 | $112.34 | 2 | Tactile Systems Technology Inc ($112.34) |
| 2021 | $28.40 | 2 | CSL Behring ($16.48) |
| 2018 | $12.29 | 1 | Seattle Genetics, Inc. ($12.29) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2023 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $75.69 | General |
| Category: Oncology | ||||||
| 12/08/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $56.17 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/08/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $56.17 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/15/2021 | CSL Behring | Idelvion (Biological) | Education | In-kind items and services | $16.48 | General |
| Category: Hematology | ||||||
| 04/11/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 753 | 2,817 | $262,040 | $50,970 |
| 2022 | 19 | 773 | 21,720 | $336,640 | $73,246 |
| 2021 | 20 | 821 | 25,179 | $754,071 | $146,031 |
| 2020 | 25 | 987 | 20,210 | $818,785 | $156,493 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 146 | 455 | $57,526 | $17,326 | 30.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 22 | 98 | $81,778 | $9,690 | 11.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 131 | 663 | $23,205 | $5,032 | 21.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 27 | 78 | $23,712 | $3,709 | 15.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 65 | 231 | $14,322 | $2,372 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 36 | $6,529 | $2,252 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 242 | $4,598 | $2,025 | 44.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 184 | $17,112 | $1,919 | 11.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $4,359 | $1,438 | 33.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 47 | 91 | $5,278 | $1,216 | 23.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 22 | 94 | $9,870 | $1,116 | 11.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,460 | $872.70 | 25.2% |
| 83550 | Iron binding capacity | Office | 2023 | 47 | 86 | $2,924 | $737.02 | 25.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 13 | 31 | $4,712 | $678.90 | 14.4% |
| 83540 | Iron level | Office | 2023 | 47 | 86 | $2,236 | $545.24 | 24.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 419 | $419.00 | $38.85 | 9.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 137 | 463 | $58,537 | $19,048 | 32.5% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2022 | 13 | 18,750 | $75,750 | $16,697 | 22.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 18 | 69 | $51,788 | $7,483 | 14.4% |
| J1750 | Injection, iron dextran, 50 mg | Office | 2022 | 12 | 380 | $29,598 | $4,761 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 67 | $12,150 | $4,596 | 37.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 121 | 589 | $20,615 | $4,513 | 21.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 26 | 64 | $19,456 | $3,411 | 17.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 66 | 212 | $13,144 | $2,202 | 16.8% |
| 99195 | Drawing of blood for a medical problem | Office | 2022 | 11 | 29 | $8,910 | $2,018 | 22.6% |
About Dr. Daniel Temeles, M.D
Dr. Daniel Temeles, M.D is a Hematology & Oncology healthcare provider based in Roanoke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699741629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Temeles, M.D has received a total of $228.72 in payments from pharmaceutical and medical device companies, with $75.69 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($188.03).
As a Medicare-enrolled provider, Temeles has provided services to 3,334 Medicare beneficiaries, totaling 69,926 services with total Medicare billing of $426,741. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Roanoke, VA
- Active Since 02/28/2006
- Last Updated 11/02/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1699741629
Products in Payments
- Flexitouch Plus (Device) $112.34
- XPOVIO (Drug) $75.69
- Idelvion (Biological) $16.48
- ADCETRIS (Biological) $12.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Roanoke
Amanda Gillespie-Twardy, M.d, M.D
Hematology & Oncology — Payments: $15,362
Mark Kochenderfer, Md, MD
Hematology & Oncology — Payments: $12,819
Dr. Padmaja Mallidi, M.d, M.D
Hematology & Oncology — Payments: $1,580
Dr. Harry Mccoy, M.d, M.D
Hematology & Oncology — Payments: $544.52
Mrs. Kirsten Hinson, Fnp-C, FNP-C
Hematology & Oncology — Payments: $421.40
Joshua Morales, Md, MD
Hematology & Oncology — Payments: $412.41